Back to Menu
Basis for Thyroid Cancer Diagnosis
1.Clinical symptom assessment
A hard, fixed thyroid nodule on neck palpation accompanied by lymphadenopathy should raise suspicion for malignancy.
2.Ultrasonographic evaluation
The first-line modality. Malignant features include hypoechogenicity, microcalcifications, and a taller-than-wide shape (anteroposterior-to-transverse ratio > 1).
3.Blood testing and analysis
Calcitonin supports diagnosis of medullary thyroid carcinoma, and thyroglobulin (Tg) is used for postoperative recurrence monitoring.
4.Fine-needle aspiration biopsy
Ultrasound-guided cytology is the gold standard for characterizing thyroid nodules.
5.Molecular marker testing
BRAF mutations have high predictive value, and gene classifiers assist in differentiating benign from malignant lesions.
6.Radionuclide scanning
Most thyroid cancers present as “cold nodules,” and specificity is limited; results should be interpreted in context.
7.CT and MRI
Used to assess extent of invasion, airway compression, and lung metastasis, and to support surgical planning.
8.Intraoperative frozen-section pathology
Provides rapid guidance on surgical extent and helps avoid reoperation.
9.Postoperative paraffin-embedded pathology
The definitive basis for final diagnosis, determining subtype and stage to guide adjuvant therapy.
10.Daily self-check for thyroid cancer
Observe neck symmetry in a mirror and palpate for hard nodules using three fingers; seek medical evaluation if abnormalities are noted.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that the rising incidence of thyroid cancer makes early diagnosis pivotal. Regular self-checks and ultrasound screening enable early detection. Timely standardized treatment and lifelong follow-up are central to effective disease control and improved prognosis.
Basis for Thyroid Cancer Diagnosis
1.Clinical symptom assessment
A hard, fixed thyroid nodule on neck palpation accompanied by lymphadenopathy should raise suspicion for malignancy.
2.Ultrasonographic evaluation
The first-line modality. Malignant features include hypoechogenicity, microcalcifications, and a taller-than-wide shape (anteroposterior-to-transverse ratio > 1).
3.Blood testing and analysis
Calcitonin supports diagnosis of medullary thyroid carcinoma, and thyroglobulin (Tg) is used for postoperative recurrence monitoring.
4.Fine-needle aspiration biopsy
Ultrasound-guided cytology is the gold standard for characterizing thyroid nodules.
5.Molecular marker testing
BRAF mutations have high predictive value, and gene classifiers assist in differentiating benign from malignant lesions.
6.Radionuclide scanning
Most thyroid cancers present as “cold nodules,” and specificity is limited; results should be interpreted in context.
7.CT and MRI
Used to assess extent of invasion, airway compression, and lung metastasis, and to support surgical planning.
8.Intraoperative frozen-section pathology
Provides rapid guidance on surgical extent and helps avoid reoperation.
9.Postoperative paraffin-embedded pathology
The definitive basis for final diagnosis, determining subtype and stage to guide adjuvant therapy.
10.Daily self-check for thyroid cancer
Observe neck symmetry in a mirror and palpate for hard nodules using three fingers; seek medical evaluation if abnormalities are noted.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that the rising incidence of thyroid cancer makes early diagnosis pivotal. Regular self-checks and ultrasound screening enable early detection. Timely standardized treatment and lifelong follow-up are central to effective disease control and improved prognosis.